Fig. 1
From: PRSS22 as a novel prognostic and immune regulatory biomarker in PanCancer multiomics analysis
Expression patterns and predicted structure of PRSS22 in human cancers. (A) The expression of PRSS22 mRNA across 33 types of tumors was analyzed in the TCGA databases. (B) The expression of PRSS22 mRNA across 33 types of tumors in TCGA_GTEx. (C) PRSS22 expression in paired tumor-normal samples from 23 TCGA cohorts. (D) Predicted 3D structure of PRSS22 by AlphaFold, with pLDDT confidence scores. (E) Protein expression of PRSS22 in tumor and normal tissues. (ns, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001).
